MELINTA THERAPEUTICS INC MLNT S

October 23, 2019 - 1:12pm EST by

member

						2019	2020
Price:		5.12		EPS		0	0
Shares Out. (in M):		14		P/E		0	0
Market Cap (in $M):		70		P/FCF		0	0
Net Debt (in $M):		70		EBIT		0	0
TEV (in $M):		140		TEV/EBIT		0	0
Borrow Cost:		Tight 15-50% cost

Description

Sign up or Log In

Sign up for free guest access to view investment ideas with a 45-day delay and read the full report.

Log in to read the full report.

1 show sort by

You are not eligible to view 13 messages. To gain access to more recent message posts signup free for membership.

19	member 1/15/09 10:47AM RE: RE: RE: gi03's questions 18
By under writing margins, do you mean 95% MLR, in which case the profit is really just overhead absorbtion since on an operating margin basis, after expenses, MA would be unprofitable? Thanks. view available tags
13	member 1/12/09 4:24PM statutory capital 12
Curious if you share the math behind the $6 excess capital at statutory subsidaries? thank you. view available tags
12	member 1/12/09 1:32PM RE: RE: RE: RE: RE: RE: MLR 11
as well as your estimate that LCA's MLR is 85%? view available tags
11	member 1/12/09 1:28PM RE: RE: RE: RE: RE: MLR 10
curious how you arrive at your $20m purchase price estimate for LCA? view available tags
6	member 1/08/09 2:54PM Question
Thanks for this idea. Can you expand on why GTS should be acquired by WLP? Because this is a basically local business, it's not clear to me what the leverage is in adding lives in... login to read the rest view available tags
1	member 12/31/08 4:25PM Puerto Rico and healthcare cha
nice idea and nice write up. I would appreciate your thoughts on the following: 1.) What is competition like in Puerto Rico 2.) What is worst case scenario for possible downside risks from healthcare reform for view available tags

load more messages